This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 Jan;36(1):325-6.

doi: 10.1128/JCM.36.1.325-326.1998.

Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis

M R Oggioni, G Pozzi, P E Valensin, P Galieni, C Bigazzi

PMID: 9431982
PMCID: PMC124869
DOI: 10.1128/JCM.36.1.325-326.1998

Case Reports

Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis

M R Oggioni et al. J Clin Microbiol. 1998 Jan.

. 1998 Jan;36(1):325-6.

doi: 10.1128/JCM.36.1.325-326.1998.

Authors

M R Oggioni, G Pozzi, P E Valensin, P Galieni, C Bigazzi

PMID: 9431982
PMCID: PMC124869
DOI: 10.1128/JCM.36.1.325-326.1998

No abstract available

PubMed Disclaimer

Figures

FIG. 1 — FIG. 1
Ethidium bromide-stained agarose gel of randomly amplified fragments of B. subtilis chromosomal DNA. Amplification was performed with primer GTTTCCGCCC as described in reference . Lane 1, rifampin- and novobiocin-resistant clinical isolate; lane 2, EG-RN strain; lane 3, chloramphenicol-resistant clinical isolate; lane 4, EG-CM strain; lane 5, B. subtilis ATCC 6633; lane 6, B. subtilis reference strain Marburg; lane 7, molecular weight standard (phage ΦX174 cut with restriction enzyme HaeIII).

See this image and copyright information in PMC

Similar articles

[Bacteremia Due to Bacillus subtilis: A Case Report and Clinical Evaluation of 10 Cases].
Hashimoto T, Hayakawa K, Mezaki K, Kutsuna S, Takeshita N, Yamamoto K, Katanami Y, Ohmagari N. Hashimoto T, et al. Kansenshogaku Zasshi. 2017 Mar;91(2):151-4. Kansenshogaku Zasshi. 2017. PMID: 30277700 Japanese.
Antimicrobial Peptidomimetics for Recurrent Septicemia Infections: In Vitro Study for Immuno Compromised Disease Target.
Sharma P, Nagarajan K, Panda BP. Sharma P, et al. Drug Res (Stuttg). 2018 Sep;68(9):499-503. doi: 10.1055/s-0043-119069. Epub 2018 Apr 16. Drug Res (Stuttg). 2018. PMID: 29660749
Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy.
Kay SE, Clark RA, White KL, Peel MM. Kay SE, et al. J Clin Microbiol. 2001 Feb;39(2):808-10. doi: 10.1128/JCM.39.2.808-810.2001. J Clin Microbiol. 2001. PMID: 11158159 Free PMC article.
Fulminant septicemic syndrome of Bacillus cereus in a leukemic patient.
Akiyama N, Mitani K, Tanaka Y, Hanazono Y, Motoi N, Zarkovic M, Tange T, Hirai H, Yazaki Y. Akiyama N, et al. Intern Med. 1997 Mar;36(3):221-6. doi: 10.2169/internalmedicine.36.221. Intern Med. 1997. PMID: 9144019 Review.
Bacillus sphaericus bacteraemia in children with cancer: case reports and literature review.
Castagnola E, Fioredda F, Barretta MA, Pescetto L, Garaventa A, Lanino E, Micalizzi C, Giacchino R, Dini G. Castagnola E, et al. J Hosp Infect. 2001 Jun;48(2):142-5. doi: 10.1053/jhin.2001.0995. J Hosp Infect. 2001. PMID: 11428882 Review.

See all similar articles

Cited by

Construction of Bacillus subtilis strain engineered for expression of porcine β-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity.
Xu J, Zhong F, Zhang Y, Zhang J, Huo S, Lin H, Wang L, Cui D, Li X. Xu J, et al. Asian-Australas J Anim Sci. 2017 Apr;30(4):576-584. doi: 10.5713/ajas.16.0207. Epub 2016 Jun 30. Asian-Australas J Anim Sci. 2017. PMID: 27383796 Free PMC article.
Effect of cultured white soft cheese on the histopathological changes in the kidneys and liver of albino rats.
Salman KH, Ali FAZ, Elhanbaly R. Salman KH, et al. Sci Rep. 2022 Feb 15;12(1):2564. doi: 10.1038/s41598-022-06522-y. Sci Rep. 2022. PMID: 35169197 Free PMC article.
The effect of lactic acid bacteria isolates on the urinary tract pathogens to infants in vitro.
Lim IS, Lee HS, Kim WY. Lim IS, et al. J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S57-62. doi: 10.3346/jkms.2009.24.S1.S57. Epub 2009 Jan 28. J Korean Med Sci. 2009. PMID: 19194563 Free PMC article.
Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis.
Pontarollo G, Acquasaliente L, Peterle D, Frasson R, Artusi I, De Filippis V. Pontarollo G, et al. J Biol Chem. 2017 Sep 15;292(37):15161-15179. doi: 10.1074/jbc.M117.795245. Epub 2017 Jul 6. J Biol Chem. 2017. PMID: 28684417 Free PMC article.
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.
Lopes CM, de Jesus Monteiro CS, Duarte AP, Dos Santos JL. Lopes CM, et al. J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337. J Clin Med. 2024. PMID: 39518476 Free PMC article. Review.

See all "Cited by" articles

References

1. Ciffo F. Determination of the spectrum of antibiotic resistance of the Bacillus subtilis strains of Enterogermina. Chemioterapia. 1984;3:45–52. - PubMed
1. de Boer A S, Diderichsen B. On the safety of Bacillus subtilis and B. amyloliquefaciens: a review. Appl Microbiol Biotechnol. 1991;36:1–4. - PubMed
1. Frank, O. (World Health Organization). Personal communication.
1. Kiss T, Gratwohl A, Frei R, Osterwalder B, Tichelli A, Speck B. Bacillus subtilis infections. Schweiz Rundsch Med Prax. 1988;77:1219–1223. - PubMed
1. Mazza P, Zani F, Martelli P. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll Chim Farm. 1992;131:401–408. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
Molecular Biology Databases
- SILVA